The Economic Case for Automation & GenAI in Life Sciences R&D: Converting Potential
An ArisGlobal best practice guide, informed by investor insight from Nordic Capital
An ArisGlobal best practice guide, informed by investor insight from Nordic Capital
Embed the latest Gen AI and LLM-powered technologies powered by LifeSphere NavaX™ across the end-to-end Regulatory lifecycle.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved